Role of biotransformation in 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats
- 4 September 2008
- journal article
- Published by Elsevier BV in Toxicology
- Vol. 250 (2-3), 100-108
- https://doi.org/10.1016/j.tox.2008.06.006
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Effect of gender, dose, and time on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT)-induced hepatotoxicity in Fischer 344 ratsXenobiotica, 2008
- Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT–PCRJournal of Biochemical and Molecular Toxicology, 2006
- METABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTESDrug Metabolism and Disposition, 2005
- Troglitazone and liver injury: In search of answersHepatology, 2005
- Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro ModelsThe Journal of Clinical Pharmacology, 2001
- Hepatotoxicity with ThiazolidinedionesDrug Safety, 2001
- Role of CYP3A in Ethanol-Mediated Increases in Acetaminophen HepatotoxicityToxicology and Applied Pharmacology, 1997
- Zonation of cytochrome P450 expression, drug metabolism and toxicity in liverGeneral Pharmacology: The Vascular System, 1997
- Acute hepatic and renal toxicity of dichlorobenzene isomers in fischer 344 ratsJournal of Applied Toxicology, 1993
- Studies on Biological Activity of Cyclic Imide CompoundsAgricultural and Biological Chemistry, 1971